Experimental Biological/Vaccine,Placebo Comparator Biological/Vaccine
Sponsors
None, Inovio Pharmaceuticals, Inc., Faculty of Medicine Ramathibodi Hospital, Research Administration Section, Faculty of Medicine, Thammasat university (Rangsit campus), Bavarian Nordic A/S
Conditions
Adult solid organ transplant recipients
Monoclonal antibody kidney liver heart transplantCervical Dysplasia
Cervical High Grade Squamous Intraepithelial Lesion
HSILChikungunya disease
Chikungunya virus virus-like particle, Chikungunya Disease, ImmunogenicityMelasma
Melasma, chloasma, chloasma faciei, platelet rich fibrin, PRF, Autologous platelet concentration, APCPain and anxiety during endometrial sampling in women age at least 35 years old with abnormal uterine bleeding
lavender aroma, pain, anxiety, endometrial sampling, abnormal uterine bleedingUrogenital atrophy
vaginal atrophy
urethral atrophy
urinary incontinence
pueraria mirificapediatric drug-resistant epilepsy patients
Epilepsy, drug-resistance, lavender
Phase 2
Phase 3
REVEAL 1 (Randomized Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)
Active, not recruitingTCTR20170301001
Start: 2017-06-28Updated: 2026-08-03
Efficacy of lavender aroma inhalation for pain and anxiety relief during endometrial sampling in women age at least 35 years old with abnormal uterine bleeding; randomized single-blind controlled trial
RecruitingTCTR20240522002
Start: 2024-05-12Target: 140Updated: 2026-08-03
A Phase 3b Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of an Adjuvanted Chikungunya Virus Virus-like Particle (CHIKV VLP) Vaccine for the Prevention of Chikungunya Disease in Adolescents (12 to 18 Years) and Adults (18 Years or more than)
Active, not recruitingTCTR20240812007
Start: 2026-06-04Target: 6144Updated: 2026-08-03
Lavender aromatherapy as an adjunctive therapy for pediatric drug-resistant epilepsy patients: a randomized-placebo controlled trial
RecruitingTCTR20250130002
Start: 2025-02-03Target: 120Updated: 2026-08-03
The Efficacy of Intralesional Platelet-rich Fibrin Injection Compared to Intralesional Normal Saline Injection of Melasma: A Randomized, Split-face, Prospective Control Trial
Active, not recruitingTCTR20260310005
Start: 2026-04-20Target: 15Updated: 2026-08-03